Gestasyonel diabetes mellitus tanı ve tedavisi

Gestasyonel diyabet ilk kez gebelikte ortaya çıkan ya da gebelik sırasında tanı konulan glukoz tolerans bozuklu-ğudur. Farklı toplumlarda %1–14 oranlarında bildirilmek-tedir. Sıklığı giderek artmaktadır. Tarama testleri genel-likle gebeliğin 24–28. haftalarında yapılmaktadır. Tanıda ise 75 ya da 100 gram OGTT kullanılmaktadır. Diyet ve egzersizle kan şekeri düzenlenemeyen hastalarda insülin tedavisine geçilir. Oral antidiyabetiklerin gestasyonel diyabette kullanımı ile ilgili çalışmalar devam etmektedir. Erken tanı ve yakın takiplerle günümüzde komplikasyon oranları son derece azalmıştır. Bu hastaların postpartum dönemde Tip 2 diyabet gelişimi yönünden bilgilendiril-meleri ve takip edilmeleri gerekmektedir.

Gestational diabetes mellitus diagnosis and treatment

Gestational Diabetes Mellitus is defined as glucose intolerance that comes out or is first recognized during pregnancy, and disappears after delivery. In different studies it’s incidence is reported in between 1-14% and the incidence is increasing. Screening tests are generally recommended in 24th-28th weeks of pregnancy. The 75 or 100 gram OGTT is the diagnostic test. If the blood glucose levels can not be regulated with diet or exercise, insulin treatment is another option. Studies dealing with the use of oral antidiabetics in GDM treatment are challenging. Nowadays the complication rates are very low due to early diagnosis and close chasing. These patients should be followed up after pregnancy for the development of Diabetes Mellitus Type 2. In this review we aim to discuss GDM diagnosis, incidence, risks and treatment.

___

  • Turok DK, Ratcliffe SD, Baxley AG. Management of gestational diabetes mellitus. Am Fam Physician 2003;68: 1769–72.
  • Dornhorst A, Paterson CM, Nicholls JS, Wadsworth J, Chiu DC, Elkeles RS, et al. High prevalence of gestational diabetes in women from ethnic minority groups. Diabet Med 1992;9: 820–825.
  • Marquette GP, Klein VR, Niebyl JR. Efficacy of screening for gestational diabetes. Am J Perinatol 1985;2: 7–9.
  • Kim C, Tabaei BP, Burke R, McEwen LN, Lash RW, Johnson SL, et al. Missed opportunities for type 2 diabetes mellitus screening among women with a history of gestational diabetes mellitus. Am J Public Health 2006;96: 1643-8.
  • Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of Type 2 diabetes: a systematic review. Diabetes Care 2002;25: 1862-8.
  • Benjamin F, Wilson SJ, Deutsch S, Seltzer VL, Droesch K, Droesch J. Effect of advancing pregnancy on the glucose tolerance test and on the 50-g oral glucose load screening test for gestational diabetes. Obstet Gynecol 1986;68: 362–65.
  • Egeland GM, Skjærven R, Irgens LM. Birth characteristics of women who develop gestational diabetes: population based study. BMJ 2000;321: 545–7.
  • Brody SC, Harris R, Lohr K. Screening for gestational diabetes: a summary of the evidence for the U.S. Preventive Services Task Force. Obstet Gynecol 2003;101: 380–92.
  • Gestational diabetes mellitus. Diabetes Care 2003;26: 103–5.
  • Berger H, Crane J, Farine D. Screening for gestational diabetes mellitus. JOGC 2002;24: 894–912.
  • Jovanovic-Peterson L, Peterson CM, Reed GF, Metzger BE, Mills JL, Knopp RH, et al. Maternal postprandial glucose levels and infant birth weight: the diabetes in early pregnancy study. Am J Obstet Gynecol 1991;164: 103–11.
  • Cousins L, Dattel BJ, Hollingsworth DR, Zettner A. Glycosylated hemoglobin as a screening test for carbohydrate intolerance in pregnancy. Am J Obstet Gynecol 1984;150: 455–60.
  • Nasrat HA, Ajabnoor MA, Ardawi MSM. Fructosamine as a screening-test for gestational diabetes mellitus: a reappraisal. Int J Gynaecol Obstet 1990;34: 27–33
  • Scott DA, Loveman E, McIntyre L, Waugh N. Screening for gestational diabetes: a systematic review and economic evaluation. Health Technol Assess 2002;6: 1–161.
  • Grandjean H, Sarramon MF, De Mouzon J, Reme JM, Pontonnier G. Detection of gestational diabetes by means of ultrasonic diagnosis of excessive fetal growth. Am J Obstet Gynecol 1980;138: 790–2.
  • O’Sullivan JB, Mahan CM. Criteria for the oral glucose tolerance test in pregnancy. Diabetes 1964;13: 278–85.
  • National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979;28: 1039–57.
  • Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 1982;144: 768–73.
  • Meltzer S, Leiter L, Daneman D, Gerstein HC, Lau D, Ludwig S, et al. 1998 clinical practice guidelines for the management of diabetes in Canada. CMAJ 1998; 159:1–29.
  • Alberti KGMM, Zimmet PZ; for the WHO Consultation. Definition, diagnosis and classification of diabetes mellitus and its complications, Part 1: Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med 1998;15: 539–53.
  • Jolly MC, Sebire NJ, Harris JP, Regan L, Robinson S. Risk factors for macrosomia and its clinical consequences: a study of 350,311 pregnancies, Eur J Obstet Gynecol Reprod Biol 2003;111: 9–14.
  • Naylor CD, Sermer M, Chen E, Sykora K. Cesarean delivery in relation to birth weight and gestational glucose tolerance. Pathophysiology or practice style? JAMA 1996;275: 1165–70.
  • Ogonowski J, Miazgowski T, Czeszyńska MB, Jaskot B, Kuczyńska M, Celewicz Z. Factors influencing risk of macrosomia in women with gestational diabetes mellitus undergoing intensive diabetic care. Diabetes Res Clin Pract 2008;80: 405-10.
  • Ecker JL, Greenberg JA, Norwitz ER, Nadel AS, Repke JT Birth weight as a predictor of brachial plexus injury. Obstet Gynecol 1997;89: 643–7.
  • Ogata ES. Perinatal morbidity in offspring of diabetic mothers. Diabetes Rev 1995;3: 652–7.
  • O'Sullivan JB, Charles D, Mahan CM, Dandrow RV. Gestational diabetes and perinatal mortality. Am J Obstet Gynecol 1973;116: 901–4.
  • Nachum Z, Ben-Shlomo I, Weiner E, Shalev E. Twice daily versus four times daily insulin dose regimens for diabetes in pregnancy: randomised controlled trial. BMJ 1999;319: 1223–7.
  • Henry OA, Beischer NA, Sheedy MT, Walstab JE. Gestational diabetes and follow-up among immigrant Vietnam-born women. Aust NZ J Obstet Gynecol 1993;33: 109–14.
  • Rizzo T, Metzger BE, Burns WJ, Burns K. Correlations between ante partum maternal metabolism and intelligence of offspring. N Engl J Med 1991;325: 911–6.
  • American Diabetes Association. Position statement. Gestational diabetes mellitus. Diabetes Care 29 (Suppl.) (2006).
  • Gilmartin AB, Ural SH, Repke JT. Gestational diabetes mellitus. Rev Obstet Gynecol 2008;1: 129-34.
  • Langer O, Levy J, Brustman L, Anyaegbunam A, Merkatz R, Divon M. Glycaemic control in gestational diabetes mellitus how tight is tight enough: small for gestational age versus large for gestational age? Am J Obstet Gynecol 1989;161: 646–53.
  • Elliott BD, Schenker S, Langer O, Johnson R, Prihoda T Compara-tive placental transport of oral hypoglycemic agents in humans: a model of human placental drug transfer. Am J Obstet Gynecol 1994;171: 653–60.
  • Nicholson W, Bolen S, Witkop CT, Neale D, Wilson L, Bass E. Benefits and Risks of Oral Diabetes Agents Compared With Insulin in Women With Gestational Diabetes: A Systematic Review. Obstet Gynecol 2009;113: 193-205.
  • Bertini AM, Silva JC, Taborda W, Becker F, Bebber FR, Zucco V, et al. Perinatal outcomes and the use of oral hypoglycemic agents. J Perinat Med 2005;33: 519–23.
  • Lurie S, Insler V, Hagay ZJ. Induction of labor at 38 to 39 weeks of gestation reduces the incidence of shoulder dystocia in gestational diabetic patients class A2. Am J Perinatol 1996;13: 293–6.
  • Witkop CT, Neale D, Wilson LM, Bass EB, Nicholson WK. Active compared with expectant delivery management in women with gestational diabetes: a systematic review. Obstet Gynecol 2009;113: 206-17.